Neha
21 Aug • 10:19 AM · SEBI-Registered Analyst
Stocks With Strong Future Guidance — Worth Tracking
• V-Marc
• RR Kabel
• Finolex
• HFCL
Acutaas Chemicals Ltd share price is currently ₹3,224.39, down by - ₹37.28 (1.14%) from its previous closing price of ₹3,261.67. The share price has declined -0.62% over the past month and gained 132.69% over the past year. The stock's 52-week low and high are ₹1,282.06 and ₹3,698.48, respectively. Acutaas Chemicals Ltd has a market capitalisation of ₹ 25,950.00 Cr. The share price was last updated on 26 Aug 2026, 03:57 PM IST.

Updated: 26 Aug 2026, 03:57:23 pm IST

Mutual Fund Holder | Jun 26 Shares held | Jul 26 Shares held |
|---|---|---|
| Motilal Oswal Flexi Cap Fund - Regular Plan - Growth | 5.24 Lac | 10.86 Lac (107.16%) |
| SBI Healthcare Opportunities Fund - Regular Plan - IDCW | 9.00 Lac | 9.00 Lac no change |
| Kotak Multicap Fund - Regular Plan - Growth | 12.16 Lac | 8.27 Lac (32%) |
| SBI Large & Midcap Fund - Regular Plan - IDCW | 4.70 Lac | 4.70 Lac no change |
| Kotak Multi Asset Allocation Fund - Regular Plan - Growth | 4.53 Lac | 4.53 Lac no change |
Acutaas Chemicals Limited, formerly Ami Organics Limited, is an India-based company, which is engaged in the manufacturing of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. It manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It has developed and commercialized over 610 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas.
Insights from SEBI-registered analysts · updated live

Today's market leaders and laggards
Waterways Leisure Tourism Ltd.
CORDELIA
₹108.18
+43.98 (68.50%)
Advit Jewels Ltd.
RAMBHAJO
₹254.09
+42.91 (20.32%)
Wonder Electricals Ltd
WEL
₹154.72
+22.36 (16.89%)
Renaissance Global Ltd
RGL
₹151.79
+20.25 (15.39%)
Genesys International Corporation Ltd
GENESYS
₹243.81
+31.52 (14.85%)